Physician profile
Sydnee Eck
NPI 1033731674
$3,559.32
in general payments reported to CMS, 2019-2025
40 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $968 · 2022: $786 · 2023: $1,190 · 2024: $161 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431 · Education: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.04 |
| Education | $374.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.78 | 2021-2025 | |
| Lilly USA, LLC | $364.65 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $307.97 | 2023-2025 | Tremfya, Remicade, Stelara |
| E.R. Squibb & Sons, L.L.C. | $244.84 | 2023-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $231.03 | 2022-2025 | Dupixent |
| Novo Nordisk INC | $221.11 | 2021-2022 | |
| Amgen INC. | $189.25 | 2021-2025 | Otezla |
| Novartis Pharmaceuticals Corporation | $154.53 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $136.88 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.31 | 2021-2023 | Spevigo |
| Leo Pharma INC. | $110.34 | 2022-2023 | Adbry |
| Genzyme Corporation | $109.51 | 2023 | |
| Sun Pharmaceutical Industries INC. | $88.06 | 2022-2023 | Ilumya, Winlevi |
| Takeda Pharmaceuticals U.S.A., INC. | $73.77 | 2021 | |
| Sanofi-Aventis U.S. LLC | $62.02 | 2021-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydnee Eck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.